Podcasts about MBC

  • 482PODCASTS
  • 3,169EPISODES
  • 43mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Feb 27, 2026LATEST

POPULARITY

20192020202120222023202420252026

Categories



Best podcasts about MBC

Show all podcasts related to mbc

Latest podcast episodes about MBC

Free The Rabbits
18 Hybrid Babies: The Giovanna Podda Story

Free The Rabbits

Play Episode Listen Later Feb 27, 2026 30:29


In 2010, Giovanna Podda, shared her terrifying story of repeated alien abductions since she was 4 years old with Mistero, and Italian conspiracy show. She lost her job, was ran out of town and largely disappeared after being discredited by some experts. However, she reappeared in 2025 on MBC's Mysterious TV Surprise in Japan, sharing the same story and incistant it was true.Merchandise: https://freetherabbits.myshopify.comBuy Me A Coffee: DonateFollow: Website | Instagram | X | FacebookWatch: YouTube | RumbleMusic: YouTube | Spotify | Apple MusicFilms: https://merkelfilms.comย Email: freetherabbitspodcast@gmail.comDistributed by: merkel.mediaOutro Music:Joel Thomas โ€“ Psy-OpYouTube | Spotify | Apple Music

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0224(ํ™”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) โ€˜๊ณต์†Œ์ทจ์†Œ๋ชจ์ž„' ์ถœ๋ฒ”โ€ฆ๊ณ„ํŒŒํ™” ์šฐ๋ ค๋Š”? - ํ•œ๋ฏผ์ˆ˜ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 24, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. 3์ฐจ ์ƒ๋ฒ• ๊ฐœ์ •์•ˆ ๋ณธํšŒ์˜ ์ƒ์ •โ€ฆ๊ตญํž˜ ํ•„๋ฒ„ ๋Œ์ž… 2. โ€˜100๋‹‰์Šค-20๋งŒ์ „์ž' ํ˜„์‹ค๋กœ 3. ์ง‘๊ฐ’ ์ƒ์Šน ๊ธฐ๋Œ€ ์„๋‹ฌ๋งŒ์— ๊บพ์˜€๋‹ค - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] โ€˜๊ณต์†Œ์ทจ์†Œ๋ชจ์ž„' ์ถœ๋ฒ”โ€ฆ๊ณ„ํŒŒํ™” ์šฐ๋ ค๋Š”? - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ํ•œ๋ฏผ์ˆ˜ ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0223(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ์ง€์„  D-100, ์กฐ๊ตญ-ํ•œ๋™ํ›ˆ ๊ฑฐ์ทจ๋Š”? - ์žฅ์œค์„  ๊ธฐ์ž

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 23, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ํŠธ๋Ÿผํ”„, 15% ๊ด€์„ธ ๊ฐ•ํ–‰ 2. ๊ฒฝ๊ธฐ์ง€์‚ฌ ์ ํ•ฉ๋„, ๊น€๋™์—ฐ ์„ ๋‘ 3. ์žฅ๋™ํ˜ "ๆŽ๊ณต์†Œ์ทจ์†Œ ๋ชจ์ž„, ๋ฏธ์นœ ์ง“" - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ์ง€์„  D-100, ์กฐ๊ตญ-ํ•œ๋™ํ›ˆ ๊ฑฐ์ทจ๋Š”? - ์žฅ์œค์„  ์ •์น˜์ „๋ฌธ๊ธฐ์ž (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0220(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž, ๊น€์ข…ํ˜ ๊ตญ๋ฏผ์˜ํž˜ ์ „ ์ตœ๊ณ ์œ„์›, ๊ฐ•์„ฑํ•„ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ๋ถ€๋Œ€๋ณ€์ธ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 20, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์žฅ๋™ํ˜, ์‚ฌ์‹ค์ƒ ๅฐน์–ด๊ฒŒ์ธ ์„ ์–ธ 2. ๋ฏผ์ฃผ 'ๅฐน ์‚ฌ๋ฉด ๊ธˆ์ง€๋ฒ•' ์‹ ์† ์ฒ˜๋ฆฌ 3. ์œ ์‹œ๋ฏผ "๏งก ๊ณต์†Œ์ทจ์†Œ ๋ชจ์ž„, ๋ฏธ์ณค๋‚˜" - MBC ์ด์ •์€ ๊ธฐ์ž - ๊น€์ข…ํ˜ ๊ตญ๋ฏผ์˜ํž˜ ์ „ ์ตœ๊ณ ์œ„์› - ๊ฐ•์„ฑํ•„ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ๋ถ€๋Œ€๋ณ€์ธ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0219(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆ๋Œ€๋‹ด) โ€˜๋‚ด๋ž€ ์šฐ๋‘๋จธ๋ฆฌ' ์œค์„์—ด 1์‹ฌ ์„ ๊ณ  ? ์ถ”๋ฏธ์•  ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›&๋ฐ•์€์ • ์กฐ๊ตญํ˜์‹ ๋‹น์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 19, 2026


1๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์œค์„์—ด ๋‚ด๋ž€ 1์‹ฌ โ€˜๋ฌด๊ธฐ์ง•์—ญ' 2. ๅฐน ๋ฌด๊ธฐ์ง•์—ญโ€ฆ์ •์น˜๊ถŒ ๋ฐ˜์‘์€ 3. ๆŽ "๋ง๊ตญ์  ๋ถ€๋™์‚ฐ ๊ณตํ™”๊ตญ ๊ทน๋ณตํ•ด์•ผ" - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) 2๋ถ€ [์ด์Šˆ๋Œ€๋‹ด] โ€˜๋‚ด๋ž€ ์šฐ๋‘๋จธ๋ฆฌ' ์œค์„์—ด 1์‹ฌ ์„ ๊ณ  - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์ถ”๋ฏธ์•  ์˜์› - ์กฐ๊ตญํ˜์‹ ๋‹น ๋ฐ•์€์ • ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0216(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ํ•ฉ๋‹น-์ˆ™์ฒญโ€ฆ์„ค ๋ฐฅ์ƒ ์˜ค๋ฅผ ์ •์น˜๊ถŒ ์˜์ œ๋Š”? - ์žฅ์œค์„  ์ •์น˜์ „๋ฌธ๊ธฐ์ž

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 16, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋Œ€ํ†ต๋ น ์ง€์ง€์œจ 64%โ€ฆ่ˆ‡ 46% vs ้‡Ž 23% 2. ์„œ์šธ์‹œ์žฅ ์ •์›์˜ค 40% vs ์˜ค์„ธํ›ˆ 36% 3. ์ •๋ถ€ ์ฆ์‹œ ์ •์ฑ…โ€ฆ์ƒ์œ„์ธต 68% '์ž˜ํ•œ๋‹ค' - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] ํ•ฉ๋‹น-์ˆ™์ฒญโ€ฆ์„ค ๋ฐฅ์ƒ ์˜์ œ๋Š”? - ์žฅ์œค์„  ๊ธฐ์ž (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0213(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ๏งก ๋Œ€ํ†ต๋ น, ๋‹ค์ฃผํƒ์ž์— ๋˜ ๊ฒฝ๊ณ  ? ์ด๊ด‘์ˆ˜ ๊ด‘์ˆ˜๋„ค ๋ณต๋•๋ฐฉ ๋Œ€ํ‘œ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 13, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๊ณ ์„ฑ๊ตญ, '๊ฐ€๋•๋„ ํ…Œ๋Ÿฌ ์˜ํ˜น' ์ œ๊ธฐ ๋ฐ•์„ ์› ๊ณ ์†Œ 2. ๆŽ '๋‹ค์ฃผํƒ์ž ๋Œ€์ถœ ์—ฐ์žฅ' ์ €๊ฒฉ 3. โ€˜1๋…„ 8๊ฐœ์›”' ๊น€๊ฑดํฌ, ํ•ญ์†Œ ์ด์œ ์„œ ์ œ์ถœ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] ๏งก ๋Œ€ํ†ต๋ น, ๋‹ค์ฃผํƒ์ž์— ๋˜ ๊ฒฝ๊ณ  - ์ด๊ด‘์ˆ˜ ๊ด‘์ˆ˜๋„ค ๋ณต๋•๋ฐฉ ๋Œ€ํ‘œ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0212(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ์ด์ƒ๋ฏผ 1์‹ฌ ์ง•์—ญ 7๋…„โ€ฆ์ ์ ˆํ•œ๊ฐ€? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ&์žฅ์„ฑ์ฒ  ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 12, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋‹จ์ „ยท๋‹จ์ˆ˜ ์ด์ƒ๋ฏผ์— ์ง•์—ญ 7๋…„ - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ (์ถœ์—ฐ) 2. ์žฅ๋™ํ˜ ๋ถˆ์ฐธ์— ๋Œ€ํ†ต๋ น ์˜ค์ฐฌ ๋ฌด์‚ฐ 3. ๊ฐ€๋•๋„ ํ…Œ๋Ÿฌ๋ฒ”, ๊ณ ์„ฑ๊ตญ ์˜ํ–ฅ ๋ฐ›์•˜๋‚˜ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ์ด์ƒ๋ฏผ 1์‹ฌ ์ง•์—ญ 7๋…„โ€ฆ์ ์ ˆํ•œ๊ฐ€? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0211(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ๋Œ€ํ†ต๋ น, ๋‚ด์ผ ์—ฌ์•ผ ๋Œ€ํ‘œ ํšŒ๋™โ€ฆ์ฃผ์š” ๋…ผ์˜๋Š”? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 11, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ํ•ฉ๋‹น ๊ฒฐ๊ตญ ๋ฌด์‚ฐโ€ฆ์ •์ฒญ๋ž˜ ๋ฆฌ๋”์‹ญ โ€˜ํƒ€๊ฒฉ' 2. ่ˆ‡ ๊ฐ•๋“๊ตฌ, '๋Œ€ํ†ต๋ น ํ•ฉ๋‹น ์ฐฌ์„ฑ' SNS ๋…ผ๋ž€ 3. ๊ตญํž˜ ์„œ์šธ์‹œ๋‹น, ๊ณ ์„ฑ๊ตญ์— ํƒˆ๋‹น ๊ถŒ์œ  - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๋Œ€ํ†ต๋ น, ๋‚ด์ผ ์—ฌ์•ผ ๋Œ€ํ‘œ ํšŒ๋™โ€ฆ์ฃผ์š” ๋…ผ์˜๋Š”? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„ (์ถœ์—ฐ)

RTร‰ - An Saol รณ Dheas
Sadhbh Nic Fhloinn agus Mairรฉad Nรญ Dhubhaigh

RTร‰ - An Saol รณ Dheas

Play Episode Listen Later Feb 9, 2026 12:39


Scolรกirรญ Phobalscoil Chorca Dhuibhne - d'รฉirigh thar bar leo i gCraabh Sclรฉip na hร‰ireann i mBรC.

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0209(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ํŠน๊ฒ€ ์ถ”์ฒœ ๋‚ดํ™โ€ฆ๋ฒ•์‚ฌ์œ„๋„ ๋ชฐ๋ž๋‚˜? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 9, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ํŠน๊ฒ€ ์ถ”์ฒœ ๋…ผ๋ž€โ€ฆโ€œ๋Œ€ํ†ต๋ น๊ป˜ ์ฃ„์†กโ€ 2. ์นœํ•œ๊ณ„ ๊น€์ข…ํ˜ ์ œ๋ช…โ€ฆ๋‹ค์Œ์€ ๋ฐฐํ˜„์ง„? 3. ํ•œ์„ฑ์ˆ™ ์žฅ๊ด€, 3์ฑ„ ๋‚ด๋†จ๋‹ค - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ํŠน๊ฒ€ ์ถ”์ฒœ ๋‚ดํ™โ€ฆ๋ฒ•์‚ฌ์œ„๋„ ๋ชฐ๋ž๋‚˜? - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ๊น€์šฉ๋ฏผ ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0206(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) โ€œ๋‚ด๊ฐ€ ๋ฐ”๋กœ ์˜ค์„ธํ›ˆ ๋Œ€ํ•ญ๋งˆ!โ€œ - ์ •์›์˜ค ์„ฑ๋™๊ตฌ์ฒญ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 6, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋ฏผ์ฃผยทํ˜์‹  ํ•ฉ๋‹น ๋Œ€์™ธ๋น„ ๋ฌธ๊ฑด ํŒŒ๋ฌธ 2. ์žฅ๋™ํ˜ '์ง ๊ฑธ๋ผ' ๋ฐœ์–ธ์— ์˜ค์„ธํ›ˆ๋„ ๋ฐ˜๋ฐœ 3. ์ฟ ํŒก ๋กœ์ €์Šค ๊ฒฝ์ฐฐ 2์ฐจ ์ถœ์„ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] โ€œ๋‚ด๊ฐ€ ๋ฐ”๋กœ ์˜ค์„ธํ›ˆ ๋Œ€ํ•ญ๋งˆ!โ€œ - ์ •์›์˜ค ์„ฑ๋™๊ตฌ์ฒญ์žฅ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0205(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ํ•ฉ๋‹น-์ œ๋ช…โ€ฆ๋‚ดํ™ ํ™•์‚ฐ๋˜๋Š” ์—ฌ์•ผ ? ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ, ์žฅ์„ฑ์ฒ  ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 5, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์ธ์‚ฌ ๊ฒ€์ฆ์— โ€˜๋‹ค์ฃผํƒ' ๋ฌป๋Š”๋‹ค 2. ์ค‘์ˆ˜์ฒญ ์ผ์›ํ™”ยท๊ณต์†Œ์ฒญ์€ โ€˜์š”๊ตฌ๊ถŒ' ๊ฐ€๋‹ฅ 2. ์žฅ๋™ํ˜ ์žฌ์‹ ์ž„ยท์‚ฌํ‡ด ์ „๋‹น์› ํˆฌํ‘œ๋กœ ๊ฒฐ์ • 3. ์กฐ๊ตญ "๋‹น ์ž‘๋‹ค๊ณ  ์ž์กด์‹ฌ๋„ ์—†๋‚˜" - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ํ•ฉ๋‹น-์ œ๋ช…โ€ฆ๋‚ดํ™ ํ™•์‚ฐ๋˜๋Š” ์—ฌ์•ผ - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

Rorshok Malawi Update
MALAWI: Polio Outbreak & more โ€“ 3rd Feb 2026

Rorshok Malawi Update

Play Episode Listen Later Feb 4, 2026 10:31 Transcription Available


Former government officials arrested, fuel levy reinstated, a cabinet reshuffle, MBC journalists suspended, new music production fees, and much more! Thanks for tuning in! Let us know what you think and what we can improve on by emailing us at info@rorshok.com. You can also contact us on Instagram @rorshok_malawi or Twitter @RorshokMalawiLike what you hear? Subscribe, share, and tell your buds.Former Government Officials Arrested For Financial Crimes: https://www.pijmalawi.org/show-story/pij-exclusive-billions-allegedly-secretly-paid-toReshuffles and Gomo's Town Hall Meetings by Emmanuel Luciano: https://mwnation.com/reshuffles-and-gomos-town-hall-meetings/ Check out our new t-shirts: https://rorshok.store/We want to get to know you! Please fill in this mini-survey: https://forms.gle/NV3h5jN13cRDp2r66Wanna avoid ads and help us financially? Follow the link: https://bit.ly/rorshok-donate

RTร‰ - An Saol รณ Dheas
Brian ร“ Broin agus Meadhbh Nรญ Chathasaigh

RTร‰ - An Saol รณ Dheas

Play Episode Listen Later Feb 4, 2026 7:02


Bainteach le Ceolfhoireann Traidisiรบnta Mhuscraรญ - beidh siad ag seinm sa Cheolรกras Nรกisiรบnta i mBรC an Sathran beag seo.

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0204(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ฃผ๊ฐ„์ •์น˜๋™ํ˜•) ํ•ฉ๋‹น๋ก  ๋‚ดํ™โ€ฆ๊ถŒ๋ ฅํˆฌ์Ÿ ๋ฒˆ์ง€๋‚˜ ? ์ด๋™ํ˜• ์ž‘๊ฐ€

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 4, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์ฒญ์™€๋Œ€ ๋‹ค์ฃผํƒ์ž ์ฐธ๋ชจ๋“ค ์ง‘ ๋‚ด๋†จ๋‹ค 2. ๋ฏผ์ฃผ๋‹น ์ตœ๊ณ ์œ„์„œ ๋˜ ํ•ฉ๋‹น ์ถฉ๋Œ 3. ็พŽ, ้Ÿ“ ๊ด€์„ธ ์ธ์ƒ ๊ด€๋ณด ๊ฒŒ์žฌ ํ˜‘์˜์ค‘ - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ฃผ๊ฐ„์ •์น˜๋™ํ˜•] ํ•ฉ๋‹น๋ก  ๋‚ดํ™โ€ฆ๊ถŒ๋ ฅํˆฌ์Ÿ ๋ฒˆ์ง€๋‚˜ - ์ด๋™ํ˜• ์ž‘๊ฐ€ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0202(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ๋ฏผ์ฃผ-ํ˜์‹  โ€˜ํ•ฉ๋‹น ๊ฐˆ๋“ฑ' ์žฌ๋ถ„์ถœโ€ฆ์ž…์žฅ์€? - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Feb 2, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋Œ€ํ†ต๋ น SNS์„œ ๋ถ€๋™์‚ฐ ๊ฐ•๊ฒฝ ๋ฉ”์‹œ์ง€ 2. ๋ฏผ์ฃผ๋‹น ์ตœ๊ณ ์œ„์„œ ํ•ฉ๋‹น ๊ฐˆ๋“ฑ ํ‘œ์ถœ 3. ์˜ค์„ธํ›ˆ "์žฅ๋™ํ˜ ๋””์Šค์นด์šดํŠธ" ์–ธ๊ธ‰ - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๋ฏผ์ฃผ-ํ˜์‹  โ€˜ํ•ฉ๋‹น ๊ฐˆ๋“ฑ' ์žฌ๋ถ„์ถœโ€ฆ์ž…์žฅ์€? - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์› (์ถœ์—ฐ)

Living Our Breast Lives
27 YEARS Living with Metastatic Breast Cancer with Thriver - Heather Jose!

Living Our Breast Lives

Play Episode Listen Later Feb 1, 2026 64:44


In this beautifully hopeful episode, Wren, the creator of the Living Our Breast Lives Podcast, is joined by the incredible Metastatic Breast Cancer Thriver, Heather Jose, the MBC thriver living with triple positive metastatic breast cancer for 27 YEARS! Heather Jose is a long-term metastatic breast cancer thriver, advocate, and the host of the podcastย I'm Still Here: Lessons from Life with Metastatic Breast Cancer. Diagnosed at 26 and living with metastatic disease for over 25 years, Heather focuses on honest, grounded conversations about what it means to live fully โ€” not just survive โ€” alongside breast cancer. After her diagnosis, Heather went on to adopt a child, redefining what building a family can look like after metastatic breast cancer and showing that life doesn't stop at a diagnosis, it evolves. She has spent decades navigating treatment, motherhood, advocacy, and survivorship, all while helping others feel less alone.Listen to this episode as it breaks down:Who is Heather Jose? โ€“ Meeting the woman behind the diagnosisHer MBC story โ€“ Diagnosed in 1998, her subtype, and how she's still here decades laterThen vs. now โ€“ What MBC treatment looked like then and how far it's comeStrength without the pressure โ€“ The moments that carried her through and why the term "inspirational" comes with a heavy weight to itLiving with grief and joy โ€“ Mourning the life imagined while fully living the one she hasMotherhood after MBC โ€“ Infertility, adoption, and expanding her family against the oddsโ€œI'm Still Hereโ€ โ€“ Why Heather launched her podcast and who it's forLong-term survivorship โ€“ What it really means and what she's still dreaming of for the future Living Our Breast Lives Information:Email: livingourbreastlivespodcast1@gmail.comInstagram: @livingourbreastlivesFounder: Wren MorrobelPersonal Instagram: @wren_morrPodcast Guest Speaker: Heather Jose's Information:Email: mail@heatherjose.comInstagram: @heatherbjoseFacebook: Heather JoseWebsite: www.heatherjose.comYouTube: I'm Still Here

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0130(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) '์ˆ˜๋„๊ถŒ 6๋งŒํ˜ธ'โ€ฆ์ง‘๊ฐ’ ๋ถˆ์•ˆ ํ•ด์†Œ๋ ๊นŒ ? ํ•œ๋ฌธ๋„ ๋ช…์ง€๋Œ€ ๊ต์ˆ˜

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 30, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. โ€˜์‚ฌ๋ฒ•๋†๋‹จ' ์–‘์Šนํƒœ 2์‹ฌ ์ง•์—ญํ˜• ์ง‘์œ  2. ์‹ ์ฒœ์ง€ ์ฒซ ์••์ˆ˜์ˆ˜์ƒ‰โ€ฅ๊ตญํž˜ ๋‹น์› ๊ฐ€์ž… ์˜ํ˜น 3. ๋ฏผ์ฃผ-ํ˜์‹  ํ•ฉ๋‹น ๋‘๊ณ  '๋ฐ€์•ฝ์„ค' ๋“ฑ์žฅ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] '์ˆ˜๋„๊ถŒ 6๋งŒํ˜ธ'โ€ฆ์ง‘๊ฐ’ ๋ถˆ์•ˆ ํ•ด์†Œ๋ ๊นŒ - ํ•œ๋ฌธ๋„ ๋ช…์ง€๋Œ€ ๋Œ€ํ•™์› ์‹ค๋ฌดํˆฌ์ž๋ถ„์„ํ•™๊ณผ ๊ต์ˆ˜ (์ถœ์—ฐ)

The Korea Society
From Learning to Creating in Korea with Tyler and Nidhi

The Korea Society

Play Episode Listen Later Jan 29, 2026 61:46


January 28, 2026 - Learning the Korean language opens the doors into a completely new depth of understanding Korean culture, and perhaps a career you never imagined having. Join acclaimed media figuresย Tyler Raschย andย Nidhi Agrawalโ€”familiar faces from major Korean broadcast networks including JTBC, KBS, and MBCโ€”for a reflection on their personal journeys living in Korea and learning Korean, and how those experiences led to their new venture. In this engaging conversation, Tyler and Nidhi will delve into how language can function as both a cultural bridge and a creative medium, and how Hangeul can travel beyond Korea through design, storytelling, and shared cultural moments in everyday settings. For more information, please visit the link below: https://www.koreasociety.org/arts-culture/2111-from-learning-to-creating

Keeping Current CME
Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data

Keeping Current CME

Play Episode Listen Later Jan 29, 2026 29:08


Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases? Credit available for this activity expires: 1/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0129(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ์ฃผ๊ฐ€๋Š” ๋›ฐ์—ˆ๋Š”๋ฐโ€ฆ์‹ค๋ฌผ๊ฒฝ์ œ ํ•ด๋ฒ•์€? - ๊ตฌ์œค์ฒ  ๊ฒฝ์ œ๋ถ€์ด๋ฆฌยท์žฌ์ •๊ฒฝ์ œ๋ถ€ ์žฅ๊ด€

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 29, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ํ•œ๋™ํ›ˆ ์ œ๋ช…โ€ฆ๊ตญ๋ฏผ์˜ํž˜ ๋‚ดํ™ ๊ฒฉํ™” 2. ๅฐน ๊ด€์ € ๊ณจํ”„์—ฐ์Šต์žฅ, โ€˜์ดˆ์†Œ ๊ณต์‚ฌ'๋กœ ๊พธ๋ฉฐ 3. ์ •๋ถ€, ์„œ์šธยท์ˆ˜๋„๊ถŒ์— 6๋งŒํ˜ธ ๊ณต๊ธ‰ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] ์ฃผ๊ฐ€๋Š” ๋›ฐ์—ˆ๋Š”๋ฐโ€ฆ์‹ค๋ฌผ๊ฒฝ์ œ ํ•ด๋ฒ•์€? - ๊ตฌ์œค์ฒ  ๊ฒฝ์ œ๋ถ€์ด๋ฆฌยท์žฌ์ •๊ฒฝ์ œ๋ถ€ ์žฅ๊ด€ (์ „ํ™”)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0128(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž, ๊น€์ •ํ™˜ ๋ณ€ํ˜ธ์‚ฌ / (์ด์Šˆํ•˜์ดํ‚ฅ1) ํŠธ๋Ÿผํ”„ ๋Œ๋ฐœ ๊ด€์„ธ ์••๋ฐ•โ€ฆ๋Œ€์ฒ˜ ๋ฐฉ์•ˆ์€? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 28, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๊น€๊ฑดํฌ 1์‹ฌ ์ง•์—ญ 1๋…„ 8๊ฐœ์›” 2. ํŠธ๋Ÿผํ”„ ๊ด€์„ธ ์••๋ฐ•, ์ฟ ํŒก ๋•Œ๋ฌธ? 3. ๆŽ "๋‹ด๋ฐฐ์ฒ˜๋Ÿผ โ€˜์„คํƒ•์„ธโ€˜ ๊ฑท์ž" - ๊น€์ •ํ™˜ ๋ณ€ํ˜ธ์‚ฌ (์ถœ์—ฐ) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ํŠธ๋Ÿผํ”„ ๋Œ๋ฐœ ๊ด€์„ธ ์••๋ฐ•โ€ฆ๋Œ€์ฒ˜ ๋ฐฉ์•ˆ์€? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„ (์ถœ์—ฐ)

Research To Practice | Oncology Videos
Endocrine-Based Therapy for HR-Positive Breast Cancer โ€” Proceedings from a San Antonio 2025 Symposium Series

Research To Practice | Oncology Videos

Play Episode Listen Later Jan 27, 2026 121:08


Featuring perspectives from Dr Angela DeMichele, Dr Komal Jhaveri, Dr Erica Mayer, Dr Hope S Rugo and Dr Seth Wander, including the following topics:ย  Introduction (0:00) 1985 NCI Consensus Conference on Early Breast Cancer: Sir Richard Peto, FRS (2:01) Current Role of Genomic Assays in Treatment Decision-Making for Localized Hormone Receptor (HR)-Positive Breast Cancer โ€” Dr DeMichele (5:13) Case: A premenopausal woman in her mid 40s with an ER-positive, HER2-negative, node-negative infiltrating ductal carcinoma (IDC) after partial mastectomy/radiation therapy who enrolls in the prospective, observational FLEX study: MammaPrintยฎ low risk โ€” Laurie Matt-Amaral, MD, MPH (15:30) Case: A premenopausal woman in her mid 40s after modified radical mastectomy for T2N0 ER-positive, HER2-negative IDC with an Oncotypeย DXยฎย Recurrence Score (RSยฎ) of 19 โ€” Swati Vishwanathan, MD Case: A woman in her mid 60s with locally advanced (19 cm) ER-positive, HER2-low (IHC 1+) Stage IIIB mucinous carcinoma breast cancer and an RS of 18 โ€” Alan B Astrow, MD (22:40) Role of CDK4/6 Inhibitors and Other Novel Strategies in Therapy for HR-Positive, HER2-Negative Localized Breast Cancer โ€” Dr Jhaveri (30:18) Case: A woman in her mid 50s with ER-positive, HER2-negative Stage IIB, T2N1 IDC after neoadjuvant dose-dense AC-T, lumpectomy and adjuvant radiation therapy โ€” Eleonora Teplinsky, MD (42:14) Case: A woman in her mid 60s with ER-positive, HER2-negative breast cancer with a surgically removed solitary lung metastasis after 4 years of adjuvant letrozole โ€” Eric Fox, DO (46:32) Evolving Up-Front Treatment Paradigm for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) โ€” Dr Rugo (49:45) Case: A woman in her early 80s with Type 2 diabetes, well controlled hypertension and recurrent ER-positive, HER2-negative mBC after 4 years of adjuvant letrozole โ€” Sunil Gandhi, MD (1:02:30) Clinical Utility of Agents Targeting the PI3K/AKT/mTOR Pathway for Patients with Progressive HR-Positive mBC โ€” Dr Mayer (1:06:37) Case: A woman in her late 60s with ER-positive, HER2-low (IHC 1+), PIK3CA-mutant mBC with disease progression after 2 years of adjuvant letrozole โ€” Laila Agrawal, MD (1:20:22) Case: A woman in her early 60s with ER-positive, HER2-low PIK3CA-mutant mBC and disease progression on first-line palbociclib/fulvestrant โ€” Dr Teplinsky (1:26:36) Results from the Global Phase III lidERA Breast Cancer Trial of Giredestrant versus Standard Endocrine Therapy as Adjuvant Treatment for ER-Positive, HER2-Negative Localized Breast Cancer (1:31:48) Current and Future Role of Oral Selective Estrogen Receptor Degraders for Progressive HR-Positive mBC โ€” Dr Wander (1:42:30) Case: A woman in her early 100s with locally advanced ER-positive, HER2-negative breast cancer with disease progression on letrozole, now with an ESR1 mutation โ€” Dr Astrow (1:57:51) CME information and select publications

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0126(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ๋ฏผ์ฃผ-ํ˜์‹  ํ•ฉ๋‹น ๋ ๊นŒโ€ฆํšจ๊ณผ๋Š”? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 26, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 0. ์ฝ”์Šค๋‹ฅ 1000 ๋ŒํŒŒ 1. ์ดํ•ด์ฐฌ ์ „์ด๋ฆฌ ๋ณ„์„ธโ€ฆ5์ผ๊ฐ„ ์‚ฌํšŒ์žฅ 2. ์ดํ˜œํ›ˆ ๋‚™๋งˆโ€ฆ์ฒญ์™€๋Œ€ ์ธ์‚ฌ ๊ฒ€์ฆ ๋…ผ๋ž€ 3. ๋ฏผ์ฃผ-ํ˜์‹  ํ•ฉ๋‹น ์ œ์•ˆ ์—ฌ์ง„ - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๋ฏผ์ฃผ-ํ˜์‹  ํ•ฉ๋‹น ๋ ๊นŒโ€ฆํšจ๊ณผ๋Š”? - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ๊น€์šฉ๋ฏผ ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0123(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) โ€˜ํ•ฉ๋‹น ์ œ์•ˆ' ํ›„ํญํ’โ€ฆ์™œ ์ง€๊ธˆ? - ๋ฐ•์ˆ˜ํ˜„ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์ˆ˜์„๋Œ€๋ณ€์ธ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 23, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๊ตญํšŒ์„œ ์ดํ˜œํ›ˆ ์ฒญ๋ฌธํšŒโ€ฆ์ถ”๊ฐ€ ์˜ํ˜น ๋„๋งˆ 2. ๋ฏผ์ฃผ-ํ˜์‹  ํ•ฉ๋‹น ์ œ์•ˆ ํ›„ํญํ’ 3. ็พŽ ํˆฌ์ž์‚ฌ๋“ค "้Ÿ“ ์ •๋ถ€๊ฐ€ ์ฟ ํŒก ์ฐจ๋ณ„" - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] โ€˜ํ•ฉ๋‹น ์ œ์•ˆ' ํ›„ํญํ’โ€ฆ์™œ ์ง€๊ธˆ? - ๋ฐ•์ˆ˜ํ˜„ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์ˆ˜์„๋Œ€๋ณ€์ธ (์ถœ์—ฐ)

OncLiveยฎ On Air
S14 Ep85: Medical Crossfireโ„ข: Navigating the Expanding Arsenal of Endocrine Therapies for HR+/HER2โ€“ Metastatic Breast Cancer โ€“ How Can PROTAC ER Degradation Shift the Standard?

OncLiveยฎ On Air

Play Episode Listen Later Jan 22, 2026 30:38


In this podcast, experts William J. Gradishar, MD, FASCO, FACP; Stephanie L. Graff, MD, FACP, FASCO; and Cynthia X. Ma, MD, PhD; discuss current and emerging therapeutic options, including next-generation endocrine therapies, to target the estrogen receptor signaling pathway for the treatment of hormone receptorโ€“positive/HER2-negative (HR+/HER2โ€“) metastatic breast cancer (MBC).

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0122(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ์ •์ฒญ๋ž˜, ํ˜์‹ ๋‹น์— ํ•ฉ๋‹น ์ œ์•ˆโ€ฆ์ •์น˜๊ถŒ ํŒŒ์žฅ์€? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ, ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 22, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 0. ์ฝ”์Šคํ”ผ 5000 ์ƒˆ ์—ญ์‚ฌ ์ผ๋‹ค 1. ์ •์ฒญ๋ž˜, ๋ฏผ์ฃผ๋‹น-์กฐ๊ตญ๋‹น ํ•ฉ๋‹น ์ œ์•ˆ 2. ์ด์ƒ๋ฏผยท๋ฐ•์„ฑ์žฌ๋„ โ€˜์ค‘ํ˜•' ์ฒ ํ‡ด ๋งž๋‚˜? 3. ๊น€๋ณ‘๊ธฐ ๋ฐฐ์šฐ์ž ๊ฒฝ์ฐฐ ํ”ผ์˜์ž ์ถœ์„ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ์ •์ฒญ๋ž˜, ํ˜์‹ ๋‹น์— ํ•ฉ๋‹น ์ œ์•ˆโ€ฆ์ •์น˜๊ถŒ ํŒŒ์žฅ์€? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0121(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ฃผ๊ฐ„์ •์น˜๋™ํ˜•) ๊ฒ€์ฐฐยท์ดํ˜œํ›ˆยท์ง‘๊ฐ’โ€ฆ์—ญ๋Œ€ ์ตœ์žฅ ๋Œ€ํ†ต๋ น ๊ธฐ์žํšŒ๊ฒฌ ? ์ด๋™ํ˜• ์ž‘๊ฐ€

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 21, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] [๋ฏธ๋‹ˆ์ธํ„ฐ๋ทฐ] 1. โ€œ12.3์€ ๋‚ด๋ž€โ€โ€ฆํ•œ๋•์ˆ˜, ์ง•์—ญ 23๋…„ - ๊น€์ •ํ™˜ ๋ณ€ํ˜ธ์‚ฌ (์ „ํ™”) 2. ์ด์žฌ๋ช… ๋Œ€ํ†ต๋ น ์‹ ๋…„ ๊ธฐ์žํšŒ๊ฒฌ 3. ํ™์ค€ํ‘œ "ๅฐน, ์‹ ์ฒœ์ง€ ๋ชฐํ‘œ๋กœ ํ›„๋ณด ๋๋‹ค" - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ฃผ๊ฐ„์ •์น˜๋™ํ˜•] ๊ฒ€์ฐฐยท์ดํ˜œํ›ˆยท์ง‘๊ฐ’โ€ฆ์—ญ๋Œ€ ์ตœ์žฅ ๋Œ€ํ†ต๋ น ๊ธฐ์žํšŒ๊ฒฌ - ์ด๋™ํ˜• ์ž‘๊ฐ€ (์ถœ์—ฐ)

Outcomes Rocket
Why Coordinated Behavioral Health Care Consistently Delivers Better Outcomes with Colleen Marshall, Chief Clinical Officer at Two Chairs

Outcomes Rocket

Play Episode Listen Later Jan 20, 2026 14:54


High-quality behavioral healthcare scales only when outcomes, engagement, and coordination are designed into the system from day one. In this episode, Colleen Marshall, Chief Clinical Officer at Two Chairs, discusses how integrating therapy and psychiatry under one roof improves outcomes, reduces drop-off, and removes friction for patients. She explains measurement-based care (MBC), why real-time feedback in sessions drives better results, and how clinician training unlocks adoption. Colleen explores patient engagement, including why rapid access and strong matching matter and how coordinated care prevents conflicting treatment plans. She also breaks down value-based care in behavioral health, sharing how outcomes and retention can anchor shared-risk partnerships with payers. Finally, Colleen looks ahead to the future of behavioral health, including the responsible use of AI to support clinicians while maintaining ethical and effective care. Tune in and learn how outcomes, engagement, and coordination can redefine success in behavioral healthcare! Resources: Connect with and follow Colleen Marshall on LinkedIn. Follow Two Chairs on LinkedIn and visit their website.

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0119(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) โ€œ๊ฒ€์ฐฐ๊ฐœํ˜ ์ •๋ถ€์•ˆ, ์ „๋ฉด ์ˆ˜์ •ํ•ด์•ผโ€ - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์ˆ˜์„์ตœ๊ณ ์œ„์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 19, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๊น€๋ณ‘๊ธฐ, ์žฌ์‹ฌ ํฌ๊ธฐ ์ด์–ด ํƒˆ๋‹น๊ณ„ ์ œ์ถœ 2. '์ดํ˜œํ›ˆ ์ฒญ๋ฌธํšŒ' ํ›„๋ณด ์—†์ด ๊ณต๋ฐฉ๋งŒ 3. ํ•œ๋™ํ›ˆ โ€œ์†ก๊ตฌโ€โ€ฆ์žฅ๋™ํ˜์€ ์นจ๋ฌต - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] โ€œ๊ฒ€์ฐฐ๊ฐœํ˜ ์ •๋ถ€์•ˆ, ์ „๋ฉด ์ˆ˜์ •ํ•ด์•ผโ€ - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0116(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ๋ฒ•์› "ๅฐน, ๊ฒฝํ˜ธ์ฒ˜ ์‚ฌ์‹ค์ƒ ์‚ฌ๋ณ‘ํ™”" - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์œค๊ฑด์˜ ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 16, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋ฒ•์›, ๅฐน ์ฒดํฌ ๋ฐฉํ•ด ํ˜์˜ ๋“ฑ '์ง•์—ญ 5๋…„' ์„ ๊ณ  2. ๏งก๋Œ€ํ†ต๋ น-์—ฌ์•ผ ์ง€๋„๋ถ€, ๊ตญํž˜ ๋ถˆ์ฐธ ์† ์˜ค์ฐฌ 3. ๊น€๊ฒฝยท๊ฐ•์„ ์šฐยทๅ‰๋ณด์ขŒ๊ด€, ๋ชจ๋‘ ์ง„์ˆ  ์—‡๊ฐˆ๋ ค - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๋ฒ•์› "ๅฐน, ๊ฒฝํ˜ธ์ฒ˜ ์‚ฌ์‹ค์ƒ ์‚ฌ๋ณ‘ํ™”" - ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์œค๊ฑด์˜ ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0115(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ํ•œ๋™ํ›ˆ ์ œ๋ช… โ€˜๋ณด๋ฅ˜'โ€ฆๅผต ์†๋‚ด๋Š”? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ, ์žฅ์„ฑ์ฒ  ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 15, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋‚ด์ผ ๅฐน โ€˜์ฒดํฌ๋ฐฉํ•ด' ์„ ๊ณ โ€ฆ2์‹œ ์ƒ์ค‘๊ณ„ 2. ์žฅ๋™ํ˜, ํ•œ๋™ํ›ˆ ์ œ๋ช… ๊ฒฐ์ • ์—ฐ๊ธฐ 3. ๊ฒฝ์ฐฐ, ๊น€๊ฒฝ ์žฌ์†Œํ™˜โ€ฆโ€œ์‹ฌ๋ ค ๋ผ์ณ ์ฃ„์†กโ€ - MBC ์ด์ •์€ ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ํ•œ๋™ํ›ˆ ์ œ๋ช… โ€˜๋ณด๋ฅ˜'โ€ฆๅผต ์†๋‚ด๋Š”? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

Research To Practice | Oncology Videos
HER2-Positive Breast Cancer โ€” Proceedings from a San Antonio 2025 Symposium Series

Research To Practice | Oncology Videos

Play Episode Listen Later Jan 14, 2026 118:19


Featuring perspectives from Prof Giuseppe Curigliano, Prof Nadia Harbeck, Dr Ian E Krop, Dr Nancy U Lin and Dr Joyce O'Shaughnessy, including the following topics:ย  Introduction (0:00) Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer โ€” Prof Harbeck (1:39) Case: A woman in her mid 50s presents with locally advanced ER-positive, HER2-positive breast cancer โ€” Alan B Astrow, MD (12:52) Case: A woman in her mid 40s with ER-positive, HER2-positive Stage II breast cancer s/p neoadjuvant TCHP with residual disease receives adjuvant T-DM1 but discontinues due to neuropathy โ€” Laila Agrawal, MD (20:02) Previously Untreated HER2-Positive Metastatic Breast Cancer (mBC) โ€” Prof Curigliano (25:10) Case: A woman in her early 80s presents with de novo metastatic (bone-only) ER-positive, HER2-positive breast cancer โ€” Zanetta S Lamar, MD (35:03) Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer โ€” Dr Lin (46:20) Case: A woman in her early 60s with ER-positive, HER2-positive breast cancer develops a cerebellar metastasis while receiving adjuvant anastrozole after prior anti-HER2 therapy โ€” Justin Favaro, MD, PhD (59:41) Case: A woman in her early 40s with ER-negative, HER2-positive mBC develops a headache shortly after neoadjuvant TCHP, surgery and postneoadjuvant T-DM1 and is found to have an isolated 4-cm brain metastasis โ€” Dr Agrawal (1:05:36) Selection and Sequencing of Therapy for Relapsed/Refractory HER2-Positive mBC in the Absence of CNS Involvement โ€” Dr Krop (1:12:00) Case: A woman in her early 40s with ER-positive, HER2-positive mBC receives THP (docetaxel/trastuzumab/pertuzumab) and maintenance tucatinib with trastuzumab/pertuzumab on a clinical trial and now has disease progression โ€” Yanjun Ma, MD, PhD (1:23:04) Tolerability Considerations with HER2-Targeted Therapies โ€” Dr O'Shaughnessy (1:29:32) Case: A woman in her mid 60s presents with localized ER-negative, HER2-positive infiltrating ductal carcinoma โ€” Erik Rupard, MD (1:46:06) Case: A woman in her early 70s with recurrent ER-positive, HER2-positive mBC receives trastuzumab deruxtecan (T-DXd) and has concerning pulmonary symptoms but without findings on diagnostic imaging โ€” Kimberly Ku, MD Case: A woman in her mid 40s with ER-positive, HER2-positive breast cancer metastatic to the brain and lung who received multiple prior treatments responds to T-DXd but develops Grade 1 interstitial lung disease โ€” Richard Zelkowitz, MD (1:49:49) CME information and select publications

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0114(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ๋ง ๋งŽ์€ ๊ฒ€์ฐฐ๊ฐœํ˜โ€ฆ์ฒญ์™€๋Œ€ ์ž…์žฅ์€? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 14, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์œค์„์—ด ์‚ฌํ˜• ๊ตฌํ˜• 2. ๊ตญํž˜ ์œค๋ฆฌ์œ„, ํ•œ๋™ํ›ˆ ๊ธฐ์Šต ์ œ๋ช… 3. ๊น€๊ฒฝ โ€œ1์–ต ์ค„๋•Œ, ๊ฐ•์„ ์šฐ ํ•จ๊ป˜ ์žˆ์—ˆ๋‹คโ€ - MBC ํ˜„์˜์ค€ ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๋ง ๋งŽ์€ ๊ฒ€์ฐฐ๊ฐœํ˜โ€ฆ์ฒญ์™€๋Œ€ ์ž…์žฅ์€? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0112(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ๊ณต์†Œ์ฒญยท์ค‘์ˆ˜์ฒญ ์šด์˜์•ˆ ๊ณต๊ฐœโ€ฆ๊ฐœํ˜ ๋งž๋‚˜? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 12, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๊น€๊ฒฝ ๊ท€๊ตญ, ์ƒˆ๋ฒฝ๊นŒ์ง€ ๊ฒฝ์ฐฐ ์กฐ์‚ฌ 2. ๊น€๋ณ‘๊ธฐ ์ „ ์›๋‚ด๋Œ€ํ‘œ ์œค๋ฆฌ์‹ฌํŒ์› ์ถœ์„ 3. ์ƒˆ ์›๋‚ด๋Œ€ํ‘œ์— ํ•œ๋ณ‘๋„ ์˜์› ์„ ์ถœ - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๊ณต์†Œ์ฒญยท์ค‘์ˆ˜์ฒญ ์šด์˜์•ˆ ๊ณต๊ฐœโ€ฆ๊ฐœํ˜ ๋งž๋‚˜? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0109(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ์‚ฌํ˜•? ๋ฌด๊ธฐ์ง•์—ญ? ํŠน๊ฒ€ ๊ตฌํ˜• ์ „๋ง์€ ? ๋ฐ•์€์ • ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 9, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๅฐน ๋‚ด๋ž€ํ˜์˜ ๊ฒฐ์‹ฌ๊ณตํŒ 2. ์ดํ˜œํ›ˆ โ€˜๋ถ€์ ํ•ฉ' 47%, โ€˜์ ํ•ฉ' 16% 3. ๊น€๊ฒฝ, '๊ฐ•์„ ์šฐ 1์–ต' ํ˜์˜ ์ธ์ • ์ž์ˆ ์„œ ์ œ์ถœ - ์ด์ •์€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] ์‚ฌํ˜•? ๋ฌด๊ธฐ์ง•์—ญ? ํŠน๊ฒ€ ๊ตฌํ˜• ์ „๋ง์€ - ๋ฐ•์€์ • ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์› (์ถœ์—ฐ)

Research To Practice | Oncology Videos
Antibody-Drug Conjugates for Breast Cancer โ€” Proceedings from a San Antonio 2025 Symposium Series

Research To Practice | Oncology Videos

Play Episode Listen Later Jan 8, 2026 90:22


Featuring perspectives from Dr Javier Cortรฉs, Dr Rita Nanda, Prof Peter Schmid and Dr Priyanka Sharma, including the following topics:ย  Introduction (0:00) Case: A woman in her early 80s with multiple comorbidities and triple-negative breast cancer (TNBC) develops bone-only metastases 4 months after declining capecitabine for post-neoadjuvant residual disease โ€” Justin Favaro, MD, PhD (1:50) Case: A woman in her mid 70s with ER-negative, HER2-low (IHC 1+), PIK3CA-mutated, PD-L1-positive metastatic breast cancer (mBC) after receiving 3 cycles of neoadjuvant paclitaxel/carboplatin/pembrolizumab, which was discontinued โ€” Alan Astrow, MD (6:47) Previously Untreated Metastatic TNBC (mTNBC) โ€” Prof Schmid (10:47) ย Case: A woman in her early 80s with multiregimen-recurrent ER-positive, HER2-low (IHC 1+) ESR1-mutant mBC receives sacituzumab govitecan โ€” Jennifer Yannucci, MD (27:19) Case: The role of datopotamab deruxtecan (Dato-DXd) for patients with ER-positive, HER2-low mBC who experienced disease progression on prior trastuzumab deruxtecan (T-DXd) โ€” Ranju Gupta, MD;ย Case: A woman in her late 70s with bilateral recurrence in the lungs of ER-negative, HER2-low (IHC 1+) breast cancer (PD-L1 TPS 20%) receives Dato-DXd with durvalumab on protocol โ€” Yanjun Ma, MD, PhD (31:35) Integrating Antibody-Drug Conjugates (ADCs) into the Management of Endocrine-Resistant Hormone Receptor-Positive mBC โ€” Dr Sharma (36:31) Case: A woman in her early 70s with recurrent ER-negative, HER2-low (IHC 2+) mBC receives sacituzumab govitecan and achieves complete remission โ€” Dr Gupta;ย Case: Management of neutropenia associated with sacituzumab govitecan โ€” Gigi Chen, MD (50:30) Case: A woman in her late 60s with recurrent ER-negative, HER2-low (IHC 1+) mBC (HER2 V69L mutation) receives T-DXd and achieves a complete response but develops Grade 1 interstitial lung disease โ€” Dr Gupta;ย Case: Management of T-DXd-related side effects โ€” Laila Agrawal, MD (54:10) Selection and Sequencing of Therapy for Relapsed/Refractory mTNBC โ€” Dr Nanda (58:59) Case: A woman in her early 40s with multiregimen-recurrent ER-positive, HER2-low mBC who has experienced severe nausea with past treatments is about to initiate T-DXd โ€” Atif M Hussein, MD, MMM (1:12:40) Tolerability and Other Practical Considerations with ADCs and Other Cytotoxic Agents for mBC โ€” Dr Cortรฉs (1:18:10) CME information and select publications

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0108(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - ์ด์ •์€ MBC ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ๊ณต์ฒœ ์˜ํ˜น-์นœํ•œ๊ณ„ ์ถ•์ถœโ€ฆํ˜ผ๋ˆ์˜ ์—ฌ์•ผ - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ, ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 8, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. โ€˜์žฅ๋™ํ˜ ์‡„์‹ ์•ˆ' ๋‘๊ณ  ์—ฌ์ง„ 2. ๊น€๋ณ‘๊ธฐ, ์ง•๊ณ„ํšŒ์˜ ์—ฐ๊ธฐ ์š”์ฒญโ€ฆ์œค๋ฆฌ์œ„ "์˜ˆ์ •๋Œ€๋กœ" 3. ์Œ๋ฐฉ์šธ ๊น€์„ฑํƒœ "์—ฐ์–ดยท์ˆ  ํŒŒํ‹ฐ ์—†์–ด" - ์ด์ •์€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ๊ณต์ฒœ ์˜ํ˜น-์นœํ•œ๊ณ„ ์ถ•์ถœโ€ฆํ˜ผ๋ˆ์˜ ์—ฌ์•ผ - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0107(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ฃผ๊ฐ„์ •์น˜๋™ํ˜•) ์ปค์ง€๋Š” ๊น€๋ณ‘๊ธฐ ํƒˆ๋‹น ์š”๊ตฌ ? ์ด๋™ํ˜• ์ž‘๊ฐ€

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 7, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์ด ๋Œ€ํ†ต๋ น, ์ค‘๊ตญ ํ˜„์ง€์„œ ๊ธฐ์ž ๊ฐ„๋‹ดํšŒ 2. ์žฅ๋™ํ˜ โ€˜์‡„์‹ ์•ˆ' ๋ฐœํ‘œโ€ฆ๋น„์ƒ๊ณ„์—„ ์ฒซ ์‚ฌ๊ณผ 3. ๊น€๋ณ‘๊ธฐ ๋ฐฐ์šฐ์ž '๋ฒ•์นด ์‚ฌ์šฉ' ์ถ”๊ฐ€ ์˜ํ˜น ์ œ๊ธฐ - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ฃผ๊ฐ„์ •์น˜๋™ํ˜•] ์ปค์ง€๋Š” ๊น€๋ณ‘๊ธฐ ํƒˆ๋‹น ์š”๊ตฌ - ์ด๋™ํ˜• ์ž‘๊ฐ€ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0105(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ์ดํ˜œํ›ˆ, ์ฒญ๋ฌธํšŒ ๋ฌธํ„ฑ ๋„˜์„๊นŒ? - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 5, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๆŽ๋Œ€ํ†ต๋ น, ์˜ค๋Š˜ ์‹œ์ง„ํ•‘๊ณผ ์ •์ƒํšŒ๋‹ด 2. ๊ตญํž˜ ์ค‘๊ตฌ์˜์› "์ดํ˜œํ›ˆ, ๊ตฌ์˜์›์— ๊ฐ‘์งˆ" 3. ็พŽ ๋งˆ๋‘๋กœ ์ถ•์ถœโ€ฆ์„ธ๊ณ„ ๊ณณ๊ณณ ๋ฐ˜๋ฏธ ์‹œ์œ„ - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ์ดํ˜œํ›ˆ, ์ฒญ๋ฌธํšŒ ๋ฌธํ„ฑ ๋„˜์„๊นŒ? - ์‹ ์žฅ์‹ ์กฐ๊ตญํ˜์‹ ๋‹น ์ˆ˜์„์ตœ๊ณ ์œ„์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
0102(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - ์ด์ •์€ MBC ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) โ€˜๊น€๋ณ‘๊ธฐ-๊ฐ•์„ ์šฐ ์˜ํ˜นโ€˜โ€ฆ่ˆ‡ ์•…์žฌ ๋ŒํŒŒ๊ตฌ๋Š”? - ๋ฐ•ํ™๊ทผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Jan 2, 2026


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ๋ฏผ์ฃผ, ํƒˆ๋‹นํ•œ ๊ฐ•์„ ์šฐ ์ œ๋ช… ๊ฒฐ์ • 2. ์ด์žฌ๋ช… ๋Œ€ํ†ต๋ น ๊ตญ์ • ์ง€์ง€์œจ 63% 3. '๊ฐ‘์งˆ ์˜ํ˜น' ์ดํ˜œํ›ˆโ€ฆ์ง๊ถŒ๋‚จ์šฉ ํ˜์˜ ๋“ฑ ๊ณ ๋ฐœ - ์ด์ •์€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] โ€˜๊น€๋ณ‘๊ธฐ-๊ฐ•์„ ์šฐ ์˜ํ˜นโ€˜โ€ฆ่ˆ‡ ์•…์žฌ ๋ŒํŒŒ๊ตฌ๋Š”? - ๋ฐ•ํ™๊ทผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
1231(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ1) ๊ฒฝ์ œ ์‚ฌ๋ นํƒ‘์— ์ดํ˜œํ›ˆ, ๋Œ€ํ†ต๋ น์˜ ์†๋‚ด๋Š”? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Dec 31, 2025


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ํ•œ๋™ํ›ˆ, ๋‹น๋ฌด๊ฐ์‚ฌ ๊ฒฐ๊ณผ์— "๋™๋ช…์ด์ธ" 2. ๊ฒฝ์ฐฐ โ€˜๊ฐ•์„ ์šฐ 1์–ต ์ˆ˜์ˆ˜' ์ˆ˜์‚ฌ ์ฐฉ์ˆ˜ 3. ๊น€๋ณ‘๊ธฐ ๊ฐ‘์งˆ ์˜ํ˜น 10๊ฑด ๊ณต๊ณต๋ฒ”์ฃ„์ˆ˜์‚ฌ๋Œ€๋กœ - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๊ฒฝ์ œ ์‚ฌ๋ นํƒ‘์— ์ดํ˜œํ›ˆ, ๋Œ€ํ†ต๋ น์˜ ์†๋‚ด๋Š”? - ์ด๊ทœ์—ฐ ์ฒญ์™€๋Œ€ ํ™๋ณด์†Œํ†ต์ˆ˜์„ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
1229(์›”) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ๊น€๊ฑดํฌ ํŠน๊ฒ€ ๋งˆ๋ฌด๋ฆฌโ€ฆ๋‚จ์€ ์˜ํ˜น์€? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์›

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Dec 29, 2025


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์ดํ˜œํ›ˆ ๊ธฐํš์˜ˆ์‚ฐ์ฒ˜ ์žฅ๊ด€ ํ›„๋ณด์ž...๊ตญ๋ฏผ์˜ํž˜ '์ œ๋ช…' 2. ๊น€๊ฑดํฌ ํŠน๊ฒ€, ์ˆ˜์‚ฌ ๊ฒฐ๊ณผ ๋ฐœํ‘œ 3. ๆŽ๋Œ€ํ†ต๋ น ์ฒญ์™€๋Œ€ ์ฒซ ์ถœ๊ทผ - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ๊น€๊ฑดํฌ ํŠน๊ฒ€ ๋งˆ๋ฌด๋ฆฌโ€ฆ๋‚จ์€ ์˜ํ˜น์€? - ๊น€์šฉ๋ฏผ ๋”๋ถˆ์–ด๋ฏผ์ฃผ๋‹น ์˜์› (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
1226(๊ธˆ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ํŠน๋ณ„์กฐ์‚ฌ๊ตญ ํ์ง€โ€ฆ๊ฐ์‚ฌ๊ตญ ๊ฐœํ˜ ๋ฐฉ์•ˆ์€ - ๊น€์ธํšŒ ์ „ ๊ฐ์‚ฌ์›์žฅ ๊ถŒํ•œ๋Œ€ํ–‰

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Dec 26, 2025


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. ์ดˆ์œ ์˜ ์ •๋ถ€ ํŒจ์‹ฑโ€ฆ์ฟ ํŒก โ€˜์…€ํ”„์กฐ์‚ฌ' ๋…ผ๋ž€ 2. ๅฐน ์ฒซ ๊ตฌํ˜• ์ง•์—ญ 10๋…„ "์ค‘๋Œ€๋ฒ”์ฃ„ ์ฑ…์ž„" 3. ๊น€๋ณ‘๊ธฐ, ๊ณ„์†๋˜๋Š” ์˜ํ˜น ํญ๋กœ...๋‚ด์šฉ์€? - ์ด์ •์€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ] ํŠน๋ณ„์กฐ์‚ฌ๊ตญ ํ์ง€โ€ฆ๊ฐ์‚ฌ๊ตญ ๊ฐœํ˜ ๋ฐฉ์•ˆ์€ - ๊น€์ธํšŒ ์ „ ๊ฐ์‚ฌ์›์žฅ ๊ถŒํ•œ๋Œ€ํ–‰ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
1225(๋ชฉ) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ์ด์ •์€ ๊ธฐ์ž / (๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ) ํ•œ๋™ํ›ˆ-์žฅ๋™ํ˜, ํ™”ํ•ดํ•  ์ˆ˜ ์žˆ์„๊นŒ? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ, ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Dec 25, 2025


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. 3์ฒœ์ชฝ ํ†ต์ผ๊ต ๋‚ด๋ถ€๋ฌธ๊ฑด์— ๋“œ๋Ÿฌ๋‚œ ๋กœ๋น„ ์ •ํ™ฉ 2. ๊น€๋ณ‘๊ธฐ, โ€˜์ˆ™๋ฐ•๊ถŒ' ์˜ํ˜น ์ด์–ด ๊ฐ€์กฑ ์˜์ „ ๋…ผ๋ž€ 3. '์„ค๊ณ„์ž' ๋…ธ์ƒ์›์˜ ๊ณ„์—„ ์‹คํŒจ ์ˆ˜์Šต ๊ณ„ํš - ์ด์ •์€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [๊ฑฐ์นจ์—†์ดํ•˜์ดํ‚ฅ] ํ•œ๋™ํ›ˆ-์žฅ๋™ํ˜, ํ™”ํ•ดํ•  ์ˆ˜ ์žˆ์„๊นŒ? - ์‹ ์ธ๊ทœ ๋ณ€ํ˜ธ์‚ฌ - ์žฅ์„ฑ์ฒ  ๊ณต๋ก ์„ผํ„ฐ ์†Œ์žฅ (์ถœ์—ฐ)

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ
1224(์ˆ˜) 1,2๋ถ€ / (๋‰ด์Šค์‹ ์„ธ๊ณ„) - MBC ํ˜„์˜์ค€ ๊ธฐ์ž / (์ด์Šˆํ•˜์ดํ‚ฅ) ํ†ต์ผ๊ต ํŠน๊ฒ€, ์ถ”์ฒœ๊ถŒ ๋†“๊ณ  ํž˜๊ฒจ๋ฃจ๊ธฐ - ์ด๋™ํ˜• ์ž‘๊ฐ€

ํ‘œ์ฐฝ์›์˜ ๋‰ด์Šค ํ•˜์ดํ‚ฅ

Play Episode Listen Later Dec 24, 2025


1-2๋ถ€ [๋‰ด์Šค์‹ ์„ธ๊ณ„] 1. 'ํ—ˆ์œ„ยท์กฐ์ž‘์ •๋ณด ์œ ํ†ต ๊ธˆ์ง€' ๊ตญํšŒ ๋ณธํšŒ์˜ ํ†ต๊ณผ 2. ๊น€์šฉํ˜„ยท์—ฌ์ธํ˜• ์ถ”๊ฐ€ ๊ตฌ์†โ€ฆ์ฆ๊ฑฐ์ธ๋ฉธ ์šฐ๋ ค 3. ๊น€๋ณ‘๊ธฐ, ํ˜ธํ…” ์ˆ™๋ฐ•๊ถŒ ์ด์–ด '๊ฐ€์กฑ ์˜์ „โ€˜ ์˜ํ˜น - ํ˜„์˜์ค€ MBC ๊ธฐ์ž (์ถœ์—ฐ) [์ด์Šˆํ•˜์ดํ‚ฅ1] ํ†ต์ผ๊ต ํŠน๊ฒ€, ์ถ”์ฒœ๊ถŒ ๋†“๊ณ  ํž˜๊ฒจ๋ฃจ๊ธฐ - ์ด๋™ํ˜• ์ž‘๊ฐ€ (์ถœ์—ฐ)

Research To Practice | Oncology Videos
Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer โ€” Clinical Investigator Perspectives on Actual Patient Cases

Research To Practice | Oncology Videos

Play Episode Listen Later Dec 23, 2025 60:14


Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics:ย  Overview: Molecular basis of antibody-drug conjugate (ADC) toxicities โ€” Sequencing of ADCs and mechanisms of resistance (0:00) Case: A woman in her late 60s with localized triple-negative breast cancer develops myocarditis during neoadjuvant therapy with chemotherapy/pembrolizumab โ€” Richard Zelkowitz, MD (8:22) Case: A woman in her mid 70s with recurrent ER-negative, HER2-low, PD-L1-positive metastatic breast cancer (mBC) who experiences disease progression on nab paclitaxel/atezolizumab responds to sacituzumab govitecan โ€” Ranju Gupta, MD (26:43) Case: A woman in her early 80s with recurrent ER-positive, HER2-low (IHC 1+) mBC experiences disease progression on trastuzumab deruxtecan (T-DXd), then receives datopotamab deruxtecan and develops pulmonary symptoms โ€” Laila Agrawal, MD (32:11) Data Review: T-DXd (37:51) Case: A woman in her early 70s with recurrent ER-positive, HER2-low (IHC 1+) mBC, including bladder metastases, experiences disease progression after palbociclib/letrozole, then capivasertib/fulvestrant, then nab paclitaxel โ€” Justin Favaro, MD, PhD (44:02) Case: A woman in her late 70s with ER-positive, HER2-low mBC who experiences disease progression after 1 year of ribociclib/letrozole receives sacituzumab govitecan โ€” Erik Rupard, MD (55:19) CME information and select publications

Living Our Breast Lives
Immunotherapy 101 with North Star Cancer Advocacy President and MBC Advocate - Carolyn Leigh!

Living Our Breast Lives

Play Episode Listen Later Dec 15, 2025 63:30


In this educational, refreshing, and beautifully hopeful episode, Wren, the creator of the Living Our Breast Lives Podcast, is joined by the incredible Metastatic Breast Cancer Thriver, Carolyn Leigh, the President of North Star Cancer Advocacy.In 2018, she was the third member of her family to be diagnosed with metastatic breast cancer, including her mother and uncle. After her metastatic diagnosis, she spent years studying the latest scientific understandings about the immune system and immunotherapies for cancer before launching North Star Cancer Advocacy in 2022 with the aim of providing information to the community and advocating for vast increases in NIH funding. The North Star Board of Directors and the MBC community recently raised $100k to further the research of combining Natural Killer cells (immune system cells) and one of the most promising breast cancer drugs in preclinical development, ErSO-TFPy.In this episode, join me as Carolyn breaks down:ย - How the inspirational Judy Perkins and TILs therapy reshaped her belief in what's possible- The moment she decided to found North Star- A simple breakdown of MHC I expression and why some immunotherapies succeed while others don't- A crash course in how immunotherapy actually works inside the body- Her mission to raise six figures for immunotherapy-driven clinical trials โ€” and what real success would look like - How and where to access immunotherapy clinical trials- A raw conversation about allyship, momentum, and why the MBC movement can't depend solely on those living with the diseaseCarolyn isn't just an MBC advocateโ€ฆ she's a brilliant mind, a fierce researcher, the president of the North Star Cancer Research Foundation, and a woman determined to change the future of metastatic breast cancer!Living Our Breast Lives Information:Email: livingourbreastlivespodcast1@gmail.comInstagram: @livingourbreastlivesFounder: Wren MorrobelPersonal Instagram: @wren_morrPodcast Guest Speaker: Carolyn Leigh's Information:Email: NorthStarCancerAdvocacy@yahoo.comInstagram: @north.star.cancer.advocacy@north.star.cancer.researchFacebook: North Star Cancer Research FoundationWebsite: NorthStarCancerResearch.orgCRI Clinical Trial Finder:https://cri.careboxhealth.com/en-US/

Our MBC Life
S11 E3 Living Your Best Life with Palliative Care

Our MBC Life

Play Episode Listen Later Nov 19, 2025 48:43


Send us a textToday's episode tackles a topic that is often misunderstood, palliative care. Many people hear the term and immediately think of end-of-life care but that's not what palliative care is. In reality, it's about improving quality of life, managing symptoms, and helping you live as fully and comfortably as possible, no matter where you are in your metastatic breast cancer (MBC) treatment.We're joined by Dr. Jones, a palliative care physician who has worked closely with people living with MBC. He brings not only medical expertise, but also deep compassion and insight into the emotional and physical needs of our community.In this conversation, we explore:What palliative care truly meansHow to access palliative care servicesWhy integrating palliative care early can make such a meaningful differenceWhether you're newly diagnosed or have been living with MBC for many years, this episode offers clarity, reassurance, and practical information to support you on your journey.Visit OurMBCLife.org for episode notes.